SCL STEPAN CO
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · NYSE · SEC CIK 94049 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY10.0%
TTM net income YoY-90.4%
TTM EPS YoY-90.4%
Revenue 3-yr CAGR1.5%
Net income 3-yr CAGR-56.4%
Margins
Gross margin12.0%
Operating margin0.9%
Net margin0.2%
FCF margin0.2%
EBITDA margin6.0%
Returns
ROE0.4%
ROA0.2%
ROIC (approx.)1.4%
Asset turnover1.05x
Leverage & solvency
Liabilities / assets49.0%
Debt / equity0.52x
Current ratio1.32x
Interest coverage—
Cash quality & payout
Operating cash flow / net income26.52x
Accruals ratio-4.6%
Payout ratio829.6%
Capex / revenue4.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $2.33B | $2.18B |
| Cost of revenue | $2.06B | $1.91B |
| Gross profit | $269.89M | $272.21M |
| R&D expense | $34.80M | $33.54M |
| SG&A expense | $90.79M | $98.28M |
| Operating income | $78.55M | $70.48M |
| Interest expense | $30.77M | $33.03M |
| Pretax income | $59.90M | $60.44M |
| Income tax | $13.01M | $10.07M |
| Net income | $46.90M | $50.37M |
| EBITDA | $204.59M | $182.68M |
| EPS (basic) | 2.05 | 2.21 |
| EPS (diluted) | 2.05 | 2.20 |
| Dividends declared per share | 1.55 | 1.51 |
| Weighted avg. shares (diluted) | 22.89M | 22.93M |
| Balance sheet | ||
| Cash & equivalents | $132.69M | $99.67M |
| Receivables | $387.96M | $388.03M |
| Inventory | $298.83M | $288.72M |
| Current assets | $858.96M | $810.43M |
| PP&E, net | $1.22B | $1.20B |
| Goodwill | $92.57M | $91.37M |
| Intangibles | $39.53M | $42.67M |
| Total assets | $2.36B | $2.30B |
| Current liabilities | $666.49M | $669.03M |
| Short-term debt | $285.74M | $292.81M |
| Long-term debt | $340.98M | $332.63M |
| Total debt | $626.71M | $625.44M |
| Total liabilities | $1.11B | $1.13B |
| Shareholders' equity | $1.24B | $1.17B |
| Net debt | $494.02M | $525.77M |
| Cash flow statement | ||
| Operating cash flow | $147.88M | $162.05M |
| Capital expenditure | $122.51M | $122.78M |
| Free cash flow | $25.37M | $39.28M |
| Investing cash flow | -$89.05M | -$116.94M |
| Financing cash flow | -$35.44M | -$64.52M |
| Depreciation & amortization | $126.04M | $112.20M |
| Stock-based compensation | $6.00M | $5.35M |
| Dividends paid | $35.03M | $33.95M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.